APA (7th ed.) Citation

Sivaprasad, S., Margaron, P., Kotecha, A., Mathis, T., Shah, P., Rafijah, N., & Tang, Y. Baseline characteristics associated with the first year treatment interval of intravitreal faricimab in neovascular age-related macular degeneration (nAMD). BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Sivaprasad, Sobha, Philippe Margaron, Aachal Kotecha, Thibaud Mathis, Parth Shah, Neala Rafijah, and Yannan Tang. Baseline Characteristics Associated with the First Year Treatment Interval of Intravitreal Faricimab in Neovascular Age-related Macular Degeneration (nAMD). BMJ Publishing Group.

MLA (9th ed.) Citation

Sivaprasad, Sobha, et al. Baseline Characteristics Associated with the First Year Treatment Interval of Intravitreal Faricimab in Neovascular Age-related Macular Degeneration (nAMD). BMJ Publishing Group.